Conversely, in fusion-positive RMS, the overexpression of the fusion protein PAX3/PAX7-FOXO1, resulting from chromosomal translocation, leads to a more aggressive form of RMS or accounts for approximately 85% of ARMS cases. Here, FOXO1 is linked to alveolar rhabdomyosarcoma.